Health

#SFHS2611836VSet prices for certain Milnacipran pharmaceutical products in France

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This notice sets the official prices for four Milnacipran capsule products in France, including both pre-tax and consumer prices. It affects the named manufacturers and distributors, as well as pharmacies and healthcare reimbursement systems that use these prices. The listed prices take effect on 12/05/2026.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Official prices are set for four Milnacipran capsule products.
  • Each product is priced at 4.28 € before tax and 5.04 € including tax.
  • The new prices apply from 12/05/2026.

Obligations

What this law requires

high

Pharmacies, healthcare payers, and other entities using regulated medicine prices in France must apply the official prices set for the listed Milnacipran products from 12/05/2026 onward: PFHT 4,28 € and PPTTC 5,04 € for each of the four named presentations.

pharmacieshealthcare reimbursement systemsmedicine pricing/compliance teams
from 12/05/2026
operational
high

ARROW GENERIQUES and EG LABO LABORATOIRES EUROGENERICS must use the official regulated prices published for their respective Milnacipran presentations when marketing and distributing the listed products in France.

manufacturersdistributors
from 12/05/2026
operational

Affected Parties

ARROW GENERIQUESEG LABO LABORATOIRES EUROGENERICS

Tags

pharmaceutical pricing,France,medicines